Reuters logo
BRIEF-AveXis Inc to initiate study of AVXS-101 in SMA type 2 patients in Q2
December 21, 2016 / 9:15 PM / a year ago

BRIEF-AveXis Inc to initiate study of AVXS-101 in SMA type 2 patients in Q2

Dec 21 (Reuters) - AveXis Inc :

* AveXis Inc - company now expects to initiate planned study of AVXS-101 in SMA type 2 patients in Q2 2017

* AveXis Inc - expects to initiate a U.S. pivotal trial of AVXS-101 in patients with SMA type 1 in first half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below